Biotherapeutics

During the course you’ll learn about immunology, oncology, vascular biology and neuropathology. You’ll also gain the vital skills and know-how needed to develop and manufacture biotherapeutics to improve patient outcomes and healthcare delivery, for example through the use of facilities at the state-of-the-art National Institute of Bioprocessing Research and Training (NIBRT).

To qualify for the MSc in Biotherapeutics programme students will be expected to have a Second Class Honours degree (H2.1) or equivalent in a life science, pharmaceutical or chemistry discipline. Medical graduates must have a MB, BCh, BAO or equivalent from a recognised medical school. Applicants with equivalent qualifications in related areas of science and technology, or with proven and relevant industrial experience from the Healthcare/Medical/Therapeutics industry may be considered for places following interview and assessment by the programme management team, in line with standard DCU policies. International candidates who are non-native speakers of English must satisfy the University of their competency in the English language. More information about DCU's English language requirements can be found here.